tiprankstipranks
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market
Holding INTI?
Track your performance easily

Inhibitor Therapeutics (INTI) Financial Statements

28 Followers

Inhibitor Therapeutics Financial Overview

Inhibitor Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.017; its P/E ratio is -3.41; Inhibitor Therapeutics is scheduled to report earnings on May 1, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -730.96K$ -501.69K$ 864.92K$ -664.76K$ -654.52K
EBITDA$ -730.96K$ -501.69K$ 864.92K$ -664.76K$ -654.52K
Net Income Common Stockholders$ -730.96K$ -501.69K$ -684.71K$ -664.80K$ -654.52K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.38M$ 7.10M$ 7.68M$ 9.54M$ 10.10M
Total Assets$ 6.45M$ 7.17M$ 7.79M$ 9.61M$ 10.16M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.38M$ -7.10M$ -7.68M$ -9.54M$ -10.10M
Total Liabilities$ 3.04M$ 3.04M$ 3.16M$ 3.16M$ 3.04M
Stockholders Equity$ 3.41M$ 4.14M$ 4.64M$ 6.45M$ 7.11M
Cash Flow-
Free Cash Flow$ -720.44K$ -583.08K$ -1.16M$ -562.71K$ -682.61K
Operating Cash Flow$ -720.44K$ -583.08K$ -1.16M$ -562.71K$ -682.61K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Inhibitor Therapeutics Earnings and Revenue History

Inhibitor Therapeutics Debt to Assets

Inhibitor Therapeutics Cash Flow

Inhibitor Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis